CLINICAL ROLE -
NASH Affects Millions, But the Future for Treatment Remains Brighter Than Ever
Emerging treatments, collaboration between health care providers, and new policy proposals have led to a positive outlook for the future of nonalcoholic steatohepatitis (NASH) and its treatment.
Read More
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Jeff J, Mclntyre, MA, Vice President of Liver Health Programs, Global Liver Institute, discussed the clinical and economic burden of NASH
Watch
